Tyra Biosciences (TYRA) Institutional Ownership $16.39 -0.29 (-1.74%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tyra Biosciences (NASDAQ:TYRA)CurrentInstitutional OwnershipPercentage84.14%Number ofInstitutional Buyers(last 12 months)20TotalInstitutional Inflows(last 12 months)$111.46MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$5.12M Get TYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Tyra Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TYRA Institutional Buying and Selling by Quarter Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). Tyra Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/30/2024 Auour Investments LLC21,020$494K0.2%-75.3%0.040% 10/10/2024 Exchange Traded Concepts LLC8,311$195K0.0%-32.1%0.016% 10/3/2024 SG Americas Securities LLC13,211$311K0.0%N/A0.025% 8/16/2024Perceptive Advisors LLC1,007,367$16.11M0.4%+50.5%1.908% 8/14/2024Ally Bridge Group NY LLC264,660$4.23M2.5%N/A0.501% 8/14/2024HighVista Strategies LLC16,078$257K0.1%N/A0.030% Get the Latest News and Ratings for TYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tyra Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/13/2024Ensign Peak Advisors Inc190,557$3.05M0.0%N/A0.361% 8/8/2024American Century Companies Inc.170,283$2.72M0.0%+582.9%0.324% 8/5/2024Victory Capital Management Inc.47,160$754K0.0%-1.9%0.090% 8/1/2024Rhumbline Advisers23,572$377K0.0%+12.3%0.045% 7/26/2024Bank of New York Mellon Corp58,087$929K0.0%+32.8%0.111% 5/17/2024RA Capital Management L.P.10,416,609$170.83M2.2%+43.9%19.826% 5/16/2024Kynam Capital Management LP515,190$8.45M0.9%+51.4%0.981% 5/16/2024BVF Inc. IL4,661,194$76.44M2.1%+70.1%8.872% 5/10/2024Vanguard Group Inc.899,800$14.76M0.0%+18.6%1.713% 5/7/2024Oppenheimer & Co. Inc.59,576$977K0.0%N/A0.113% 4/23/2024 Fishman Jay A Ltd. MI15,000$246K0.0%N/A0.029% 3/5/2024Wellington Management Group LLP102,436$1.42M0.0%+8.8%0.238% 2/15/2024Frazier Life Sciences Management L.P.1,026,420$14.22M0.8%-0.2%2.384% 2/14/2024Artia Global Partners LP10,253$142K0.0%-77.3%0.024% 2/14/2024Kynam Capital Management LP340,190$4.71M0.5%N/A0.790% 2/6/2024AJOVista LLC4,235$59K0.1%N/A0.010% 2/5/2024Victory Capital Management Inc.50,220$696K0.0%+53.4%0.117% 1/31/2024Federated Hermes Inc.2,070$29K0.0%+1,244.2%0.005% 1/5/2024 Exchange Traded Concepts LLC9,531$132K0.0%+34.0%0.022% 12/1/2023Wellington Management Group LLP94,112$1.30M0.0%+18.5%0.219% 11/14/2023Corton Capital Inc.11,009$152K0.1%N/A0.026% 11/13/2023FMR LLC3,898,827$53.69M0.0%-5.3%9.054% 11/1/2023Simplex Trading LLC2,009$27K0.0%+198.1%0.005% 10/24/2023Bank of New York Mellon Corp41,870$577K0.0%+2.6%0.097% 10/18/2023 Exchange Traded Concepts LLC7,114$98K0.0%-19.8%0.017% 9/21/2023Barclays PLC2,788$48K0.0%-58.9%0.006% 8/24/2023Perceptive Advisors LLC360,000$6.13M0.2%-27.2%0.837% 8/15/2023BVF Inc. IL2,739,595$46.66M1.3%-15.4%6.370% 8/14/2023Driehaus Capital Management LLC150,468$2.56M0.0%+12.1%0.350% 7/24/2023 Allspring Global Investments Holdings LLC2,273$39K0.0%N/A0.005% 7/20/2023 Exchange Traded Concepts LLC8,867$151K0.0%N/A0.021% 7/18/2023 Allspring Global Investments Holdings LLC2,273$39K0.0%N/A0.005% 7/7/2023 Auour Investments LLC85,020$1.45M0.6%N/A0.200% 5/16/2023BVF Inc. IL3,239,595$52.06M1.9%+31.0%7.611% Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).5/15/2023Logos Global Management LP87,673$1.41M0.2%-20.9%0.206% 5/11/2023FMR LLC3,147,987$50.59M0.0%-18.8%7.397% 5/2/2023Victory Capital Management Inc.33,760$543K0.0%N/A0.079% 11/15/2022TCG Crossover Management LLC945,707$8.31M2.5%+5.5%2.241% 11/15/2022Logos Global Management LP127,316$1.12M0.1%-23.5%0.302% 10/28/2022Sepio Capital LP10,625$93K0.0%N/A0.025% 10/26/2022 Fishman Jay A Ltd. MI10,500$92K0.0%N/A0.025% 8/16/2022Woodline Partners LP289,172$2.07M0.0%+8.6%0.692% 8/15/2022Sio Capital Management LLC152,159$1.09M0.4%+37.0%0.364% 8/10/2022Frazier Life Sciences Management L.P.1,375,065$9.83M0.9%+3.6%3.293% 7/27/2022 Bailard Inc.12,910$92K0.0%N/A0.031% 5/17/2022Fairmount Funds Management LLC1,284,990$13.75M3.3%+99.1%3.077% 5/16/2022Frazier Life Sciences Management L.P.1,327,665$14.21M1.2%N/A3.179% 5/5/2022 New York State Common Retirement Fund10,517$113K0.0%N/A0.025% 2/19/2022Woodline Partners LP264,745$3.73M0.1%-27.7%0.642% 2/18/2022TCG Crossover Management LLC850,450$11.97M5.6%N/A2.061% 2/14/2022Boxer Capital LLC6,448,359$90.73M3.5%+2.0%15.626% 2/14/2022Perceptive Advisors LLC673,352$9.47M0.1%-31.8%1.632% 2/14/2022Nextech Invest AG2,518,582$35.44M8.2%N/A6.103% 2/8/2022Northern Trust Corp103,493$1.46M0.0%N/A0.251% 2/3/2022 Canaan Partners XI LLC4,409,991$62.05M16.0%N/A10.687% 1/24/2022Strs Ohio2,800$39K0.0%N/A0.007% 12/3/2021Perceptive Advisors LLC987,500$17.37M0.2%N/A2.393% 11/16/2021Janus Henderson Group PLC1,374,648$22.84M0.0%N/A3.331% 11/16/2021Wellington Management Group LLP695,371$12.23M0.0%N/A1.685% 11/16/2021BVF Inc. IL1,694,933$29.81M1.2%N/A4.107% 11/16/2021Boxer Capital LLC6,323,359$111.23M3.9%N/A15.323% 11/15/2021Deerfield Management Company L.P. Series C625,000$10.99M0.2%N/A1.515% 11/15/2021RA Capital Management L.P.7,236,454$127.29M1.8%N/A17.536% 11/15/2021Ensign Peak Advisors Inc125,000$2.20M0.0%N/A0.303% 11/10/2021Goldman Sachs Group Inc.207,283$3.65M0.0%N/A0.502% 11/9/2021Jennison Associates LLC468,750$8.25M0.0%N/A1.136% (Data available from 1/1/2016 forward) TYRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TYRA shares? During the previous two years, 30 institutional investors and hedge funds held shares of Tyra Biosciences. The most heavily invested institutionals were RA Capital Management L.P. ($170.83M), BVF Inc. IL ($76.44M), FMR LLC ($53.69M), Perceptive Advisors LLC ($16.11M), Vanguard Group Inc. ($14.76M), Frazier Life Sciences Management L.P. ($14.22M), and Kynam Capital Management LP ($8.45M).Learn more on TYRA's institutional investors. What percentage of Tyra Biosciences stock is owned by institutional investors? 84.14% of Tyra Biosciences stock is owned by institutional investors. Learn more on TYRA's institutional investor holdings. Which institutional investors have been buying Tyra Biosciences stock? Of the 25 institutional investors that purchased Tyra Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($3.18M), BVF Inc. IL ($2.69M), Kynam Capital Management LP ($515.19K), Perceptive Advisors LLC ($338.21K), Ally Bridge Group NY LLC ($264.66K), Ensign Peak Advisors Inc ($190.56K), and American Century Companies Inc. ($145.35K). How much institutional buying is happening at Tyra Biosciences? Institutional investors have bought a total of 7,844,860 shares in the last 24 months. This purchase volume represents approximately $126.76M in transactions. Which Tyra Biosciences major shareholders have been selling company stock? Of the 10 institutional investors that sold Tyra Biosciences stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($949.18K), BVF Inc. IL ($500K), Perceptive Advisors LLC ($134.40K), Auour Investments LLC ($64K), Logos Global Management LP ($62.39K), Artia Global Partners LP ($35K), and Exchange Traded Concepts LLC ($5.69K). How much institutional selling is happening at Tyra Biosciences? Institutional investors have sold a total of 1,757,181 shares in the last 24 months. This volume of shares sold represents approximately $28.48M in transactions. Related Companies MRUS Major Shareholders HCM Major Shareholders APLS Major Shareholders APGE Major Shareholders PTCT Major Shareholders EWTX Major Shareholders XENE Major Shareholders ZLAB Major Shareholders MLTX Major Shareholders KYMR Major Shareholders This page (NASDAQ:TYRA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
